Skip to main content

Table 5 Injectable antibiotic use and coverage, case note verification, EN-BIRTH study (n = 1015)

From: Antibiotic use for inpatient newborn care with suspected infection: EN-BIRTH multi-country validation study

Name of antibiotic Bangladesh Nepal Tanzania
Azimpur Tertiary Kushtia District Pokhara Regional Temeke Regional Muhimbili National
N = 106 N = 303 N = 344 N = 213 N = 49
n (% - CI) n (% - CI) n (% - CI) n (% - CI) n (% - CI)
Amikacin 4 (3.8 – (1.0–9.4)) 44 (14.5– (10.7–19.0)) 55 (16 – (12.2–20.3)) 0 (0) 0 (0)
Ampicillin 96 (90.6 – (83.3–95.3)) 0 (0) 257 (74.7 – (69.7–79.2)) 135 (63.4 – (56.5–69.8)) 33 (67.3– (52.4–80.0))
Ampicillin-Cloxacillin 0 (0) 0 (0) 0 (0) 63 (29.6 – (23.5–36.1)) 0 (0)
Amoxycillin-Cloxacillin 0 (0) 0 (0) 0 (0) 0 (0) 1 (2 – (0.0–10.8))
Azithromycin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Aztreonam 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Azoxystrobin (fungicide) 0 (0) 4 (1.3 – (0.3–3.3)) 0 (0) 0 (0) 0 (0)
Cefaclor 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Cefdinir-Flucloxacillin 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Cefixime 0 (0) 0 (0) 23 (6.7 – (4.2–9.8)) 0 (0) 0 (0)
Cephalexin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Cefotaxime 0 (0) 2 (0.7 – (0.0–2.3)) 38 (11 – (7.9–14.8)) 1 (0.5 – (0.0–2.5)) 1 (2 – (0.0–10.8))
Ciprofloxacin 0 (0) 0 (0) 0 (0) 0 (0) 4 (8.2 – (2.2–19.6))
Cloxacillin 2 (1.9 – (0.2–6.6) 0 (0) 0 (0) 0 (0) 0 (0)
Cefepime 2 (1.9 - (0.2–6.6)) 1 (0.3 – (0.0–1.8)) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Ceftriaxone 1 (0.9 – (0.02–5.1)) 19 (6.3 – (3.8–9.6)) 0 (0) 9 (4.2 – (1.9–7.8) 22 (44.9 – (30.6–59.7))
Flucloxacillin 1 (0.9 – (0.02–5.1)) 11 (3.6 – (1.8–6.4)) 14 (4.1 – (2.2–6.7)) 0 (0) 0 (0)
Gentamicin 98 (92.5 – (85.7–96.7) 217 (71.6 – (66.1–76.6)) 270 (78.5 – (73.7–82.7)) 197 (92.5 – (88.0–95.6) 34 (69.4 – (54.5–81.7))
Mexidin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Metronidazole 2 (1.9 – (0.2–6.6)) 56 (18.5 – (14.2–23.3)) 5 (1.5 – (0.5–3.3)) 2 (0.9 – (0.1–3.3)) 5 (10.2 – (3.3–22.2))
Moxifloxacin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Meropenem 0 (0) 85 (28.1 – (23.1–33.5)) 2 (0.6 - (0.0–2.0)) 0 (0) 2 (4.1 (0.5–13.9)
Ofloxacin 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Ceftazidime 5 (4.7 – (1.5–10.7)) 210 (69.3 – (63.7–74.4)) 4 (1.2 – (0.3–2.9) 0 (0) 0 (0)
Tobramycin 0 (0) 0 (0) 2 (0.6 - (0.0–2.0)) 0 (0) 0 (0)
Vancomycin 0 (0) 0 (0) 5 (1.5 – (0.5–3.3)) 0 (0) 0 (0)
Antibiotic - Unspecified 0 (0) 8 (2.6 – (1.1–5.1)) 0 (0) 0 (0) 0 (0)